Plataforma integral para seguimiento en tiempo real de un prototipo de bombas de infusión peristáltica, Universidad Privada del Valle, Cochabamba, Bolivia

• Autores: Martínez Montes de Oca, Keyla Mey, Fuentes Telleria, Remmy, Elias Hoyos, Sergio, Calle Viles, Eynar, Ortega Martinez, Rommer Alex
• Formato: artículo
• Fecha de Publicación: 2025
• Institución: Universidad de San Martín de Porres
• Repositorio: Horizonte médico
• Lenguaje: español
• OAI Identifier: oai:horizontemedico.usmp.edu.pe:article/3237
• Enlace del recurso: https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3237
• Nivel de acceso: acceso abierto
• Materia: Bombas de Infusión; Impresión Tridimensional; Innovación Tecnológica; Monitoreo; Sensores; Infusion Pumps; Printing, Three-Dimensional; Inventions; Monitoring; Sensors

Objective: To design and implement a comprehensive platform for the real-time tracking, traceability, and monitoring of infusion pumps, incorporating a prototype of a peristaltic infusion pump, with the purpose of optimizing intravenous therapy monitoring and enhancing the efficiency of medical and nursing staff. Materials and methods: A prototype of a peristaltic infusion pump was developed using 3D printing, a method that enables the precise and customized creation of highly durable and functional components. The prototype integrates microcontrollers and sensors capable of detectinganomalies during drug administration, ensuring constant flow control. In parallel, a digital platformwas designed with access through a web interface, allowing continuous real-time monitoring ofthe pumps. This low-cost solution, developed in Bolivia, aims to facilitate implementation insettings where existing commercial systems—although technologically advanced—are less accessible due to their high cost. The proposed system centralizes supervision and optimizes medical staff resources. Results: A series of experimental tests were conducted to evaluate the prototype’s accuracy compared to standard commercial infusion pumps by analyzing the percentage error in infusion rates. The prototype achieved an acceptable error range between -2.68 % and +2.57 %, demonstrating its accuracy and functionality. Furthermore, the digital platform proved effective in optimizing monitoring time, enabling healthcare personnel to focus on higher-priority tasks. Conclusions: The implementation of this comprehensive platformand the first prototype of a peristaltic infusion pump marks a significant step forward in intravenous therapy monitoring in Bolivia. Its low-cost design makes it a viable alternative for expanding access to real-time monitoring, promoting technological innovation, and optimizing both human and material resources in hospital settings.